MedTrace Logo

Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients

NCT03070912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257

Last updated 2025-11-28

No results posted yet for this study

Summary

ECMO has improved the outcome of heart or respiratory failure and carcinogenic shock and are increasingly used. However bleeding complications occurring in up to 50% of patients are poorly understood and worsen the overall results. The aim is to investigate the occurence of bleeding and its frequency according to the type of ECMO either veno-arterial or veno-venous. The investigators also want to assess the relation of bleeding with von Willebrand Factor defects.

Conditions

  • Von Willebrand Diseases

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Antoine RAUCH, MD,PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-19
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03070912 on ClinicalTrials.gov